Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · March 25, 2024

Effectiveness of Azathioprine vs Mycophenolate Mofetil for Myasthenia Gravis

The Lancet Neurology

 

Additional Info

The Lancet Neurology
Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study
Lancet Neurol 2024 Mar 01;23(3)267-276, P Narayanaswami, DB Sanders, L Thomas, D Thibault, J Blevins, R Desai, A Krueger, K Bibeau, B Liu, JT Guptill

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading